Mayer Eldon C. III 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Jan 11, 2022
Insider Transaction Report
Form 4
Mayer Eldon C. III
Director
Transactions
- Sale
Common Stock
2022-01-07$4.95/sh−1,560$7,722→ 46,125 total
Footnotes (2)
- [F1]These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on January 31, 2020 for 7,500 shares.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.95 to $5.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.